Does CALCIUM GLYCEROPHOSPHATE Cause Off label use? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Off label use have been filed in association with CALCIUM GLYCEROPHOSPHATE. This represents 100.0% of all adverse event reports for CALCIUM GLYCEROPHOSPHATE.
11
Reports of Off label use with CALCIUM GLYCEROPHOSPHATE
100.0%
of all CALCIUM GLYCEROPHOSPHATE reports
11
Deaths
10
Hospitalizations
How Dangerous Is Off label use From CALCIUM GLYCEROPHOSPHATE?
Of the 11 reports, 11 (100.0%) resulted in death, 10 (90.9%) required hospitalization, and 10 (90.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CALCIUM GLYCEROPHOSPHATE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does CALCIUM GLYCEROPHOSPHATE Cause?
Activated partial thromboplastin time prolonged (11)
Anaemia (11)
Analgesic therapy (11)
Antacid therapy (11)
Anticoagulant therapy (11)
Aspiration (11)
Asthenia (11)
Asthma (11)
Bacterial infection (11)
Benign prostatic hyperplasia (11)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)